Long-term maintenance of a microfluidic 3D human liver sinusoid

Ljupcho Prodanov, Rohit Jindal, Shyam Sundhar Bale, Manjunath Hegde, William J. Mccarty, Inna Golberg, Abhinav Bhushan, Martin L. Yarmush, Osman Berk Usta

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

The development of long-term human organotypic liver-on-a-chip models for successful prediction of toxic response is one of the most important and urgent goals of the NIH/DARPA's initiative to replicate and replace chronic and acute drug testing in animals. For this purpose, we developed a microfluidic chip that consists of two microfluidic chambers separated by a porous membrane. The aim of this communication is to demonstrate the recapitulation of a liver sinusoid-on-a-chip, using human cells only for a period of 28 days. Using a step-by-step method for building a 3D microtissue on-a-chip, we demonstrate that an organotypic in vitro model that reassembles the liver sinusoid microarchitecture can be maintained successfully for a period of 28 days. In addition, higher albumin synthesis (synthetic) and urea excretion (detoxification) were observed under flow compared to static cultures. This human liver-on-a-chip should be further evaluated in drug-related studies.

Original languageEnglish (US)
Pages (from-to)241-246
Number of pages6
JournalBiotechnology and Bioengineering
Volume113
Issue number1
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Microfluidics
Liver
Detoxification
Poisons
Urea
Pharmaceutical Preparations
Albumins
Animals
Cells
Membranes
Communication
Testing

Keywords

  • 3D microtissue
  • Hepatocytes
  • Liver sinusoid
  • Liver-on-a-chip
  • Microfludics

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Prodanov, L., Jindal, R., Bale, S. S., Hegde, M., Mccarty, W. J., Golberg, I., ... Usta, O. B. (2016). Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnology and Bioengineering, 113(1), 241-246. https://doi.org/10.1002/bit.25700

Long-term maintenance of a microfluidic 3D human liver sinusoid. / Prodanov, Ljupcho; Jindal, Rohit; Bale, Shyam Sundhar; Hegde, Manjunath; Mccarty, William J.; Golberg, Inna; Bhushan, Abhinav; Yarmush, Martin L.; Usta, Osman Berk.

In: Biotechnology and Bioengineering, Vol. 113, No. 1, 01.01.2016, p. 241-246.

Research output: Contribution to journalArticle

Prodanov, L, Jindal, R, Bale, SS, Hegde, M, Mccarty, WJ, Golberg, I, Bhushan, A, Yarmush, ML & Usta, OB 2016, 'Long-term maintenance of a microfluidic 3D human liver sinusoid', Biotechnology and Bioengineering, vol. 113, no. 1, pp. 241-246. https://doi.org/10.1002/bit.25700
Prodanov L, Jindal R, Bale SS, Hegde M, Mccarty WJ, Golberg I et al. Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnology and Bioengineering. 2016 Jan 1;113(1):241-246. https://doi.org/10.1002/bit.25700
Prodanov, Ljupcho ; Jindal, Rohit ; Bale, Shyam Sundhar ; Hegde, Manjunath ; Mccarty, William J. ; Golberg, Inna ; Bhushan, Abhinav ; Yarmush, Martin L. ; Usta, Osman Berk. / Long-term maintenance of a microfluidic 3D human liver sinusoid. In: Biotechnology and Bioengineering. 2016 ; Vol. 113, No. 1. pp. 241-246.
@article{b0af012962a0461188205a1ead080de9,
title = "Long-term maintenance of a microfluidic 3D human liver sinusoid",
abstract = "The development of long-term human organotypic liver-on-a-chip models for successful prediction of toxic response is one of the most important and urgent goals of the NIH/DARPA's initiative to replicate and replace chronic and acute drug testing in animals. For this purpose, we developed a microfluidic chip that consists of two microfluidic chambers separated by a porous membrane. The aim of this communication is to demonstrate the recapitulation of a liver sinusoid-on-a-chip, using human cells only for a period of 28 days. Using a step-by-step method for building a 3D microtissue on-a-chip, we demonstrate that an organotypic in vitro model that reassembles the liver sinusoid microarchitecture can be maintained successfully for a period of 28 days. In addition, higher albumin synthesis (synthetic) and urea excretion (detoxification) were observed under flow compared to static cultures. This human liver-on-a-chip should be further evaluated in drug-related studies.",
keywords = "3D microtissue, Hepatocytes, Liver sinusoid, Liver-on-a-chip, Microfludics",
author = "Ljupcho Prodanov and Rohit Jindal and Bale, {Shyam Sundhar} and Manjunath Hegde and Mccarty, {William J.} and Inna Golberg and Abhinav Bhushan and Yarmush, {Martin L.} and Usta, {Osman Berk}",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/bit.25700",
language = "English (US)",
volume = "113",
pages = "241--246",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "1",

}

TY - JOUR

T1 - Long-term maintenance of a microfluidic 3D human liver sinusoid

AU - Prodanov, Ljupcho

AU - Jindal, Rohit

AU - Bale, Shyam Sundhar

AU - Hegde, Manjunath

AU - Mccarty, William J.

AU - Golberg, Inna

AU - Bhushan, Abhinav

AU - Yarmush, Martin L.

AU - Usta, Osman Berk

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The development of long-term human organotypic liver-on-a-chip models for successful prediction of toxic response is one of the most important and urgent goals of the NIH/DARPA's initiative to replicate and replace chronic and acute drug testing in animals. For this purpose, we developed a microfluidic chip that consists of two microfluidic chambers separated by a porous membrane. The aim of this communication is to demonstrate the recapitulation of a liver sinusoid-on-a-chip, using human cells only for a period of 28 days. Using a step-by-step method for building a 3D microtissue on-a-chip, we demonstrate that an organotypic in vitro model that reassembles the liver sinusoid microarchitecture can be maintained successfully for a period of 28 days. In addition, higher albumin synthesis (synthetic) and urea excretion (detoxification) were observed under flow compared to static cultures. This human liver-on-a-chip should be further evaluated in drug-related studies.

AB - The development of long-term human organotypic liver-on-a-chip models for successful prediction of toxic response is one of the most important and urgent goals of the NIH/DARPA's initiative to replicate and replace chronic and acute drug testing in animals. For this purpose, we developed a microfluidic chip that consists of two microfluidic chambers separated by a porous membrane. The aim of this communication is to demonstrate the recapitulation of a liver sinusoid-on-a-chip, using human cells only for a period of 28 days. Using a step-by-step method for building a 3D microtissue on-a-chip, we demonstrate that an organotypic in vitro model that reassembles the liver sinusoid microarchitecture can be maintained successfully for a period of 28 days. In addition, higher albumin synthesis (synthetic) and urea excretion (detoxification) were observed under flow compared to static cultures. This human liver-on-a-chip should be further evaluated in drug-related studies.

KW - 3D microtissue

KW - Hepatocytes

KW - Liver sinusoid

KW - Liver-on-a-chip

KW - Microfludics

UR - http://www.scopus.com/inward/record.url?scp=84948106603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948106603&partnerID=8YFLogxK

U2 - 10.1002/bit.25700

DO - 10.1002/bit.25700

M3 - Article

AN - SCOPUS:84948106603

VL - 113

SP - 241

EP - 246

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 1

ER -